A framework for global surveillance of antibiotic resistance.
暂无分享,去创建一个
Ramanan Laxminarayan | Hajo Grundmann | John Stelling | Wasif Khan | Timothy Walsh | B. Sigaúque | H. Grundmann | W. Khan | R. Laxminarayan | A. Heddini | J. Stelling | K. Klugman | T. Walsh | Keith P Klugman | Andreas Heddini | Pilar Ramon-Pardo | Betuel Sigauque | P. Ramón-Pardo
[1] Ramanan Laxminarayan,et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. , 2005, The Lancet. Infectious diseases.
[2] S. Chihara,et al. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] B. Spratt,et al. Geographic Distribution of Staphylococcus aureus Causing Invasive Infections in Europe: A Molecular-Epidemiological Analysis , 2010, PLoS medicine.
[4] Z. Bhutta,et al. Hospital-acquired neonatal infections in developing countries , 2005, The Lancet.
[5] K. Manji,et al. High Rate of Fatal Cases of Pediatric Septicemia Caused by Gram-Negative Bacteria with Extended-Spectrum Beta-Lactamases in Dar es Salaam, Tanzania , 2005, Journal of Clinical Microbiology.
[6] Markus Herrmann. Monopoly pricing of an antibiotic subject to bacterial resistance. , 2010, Journal of health economics.
[7] D. Monnet,et al. Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance. , 2010, The Journal of antimicrobial chemotherapy.
[8] I. Okeke,et al. Antimicrobial resistance in developing countries , 1998, BMJ.
[9] Shou-Dong Lee,et al. First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan. , 2010, Journal of the Chinese Medical Association : JCMA.
[10] H. Goossens,et al. The more antibacterial trade names, the more consumption of antibacterials: a European study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Stephan Harbarth,et al. Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes , 2004, Emerging infectious diseases.
[12] A D LANGMUIR,et al. The surveillance of communicable diseases of national importance. , 1963, The New England journal of medicine.
[13] H. Goossens,et al. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] H. Goossens,et al. Antimicrobial Drug Use and Resistance in Europe , 2008, Emerging infectious diseases.
[15] F. Tenover,et al. Ability of Laboratories To Detect Emerging Antimicrobial Resistance: Proficiency Testing and Quality Control Results from the World Health Organization's External Quality Assurance System for Antimicrobial Susceptibility Testing , 2001, Journal of Clinical Microbiology.
[16] References , 1971 .
[17] M. Mulvey,et al. New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada , 2011, Emerging infectious diseases.
[18] P. Nordmann,et al. Spread of OXA-48-Encoding Plasmid in Turkey and Beyond , 2010, Antimicrobial Agents and Chemotherapy.
[19] A. Seck,et al. Class D OXA-48 Carbapenemase in Multidrug-Resistant Enterobacteria, Senegal , 2011, Emerging infectious diseases.
[20] Stanley M. Lemon,et al. WHO Global Strategy for Containment of Antimicrobial Resistance: Executive Summary , 2003 .
[21] D. Monnet,et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. , 2000, International journal of antimicrobial agents.
[22] J. Giesecke,et al. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[23] P. Huovinen,et al. Drug Resistance Updates , 2000, BMJ : British Medical Journal.
[24] U. Buchholz,et al. Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS) , 2002, The Journal of antimicrobial chemotherapy.
[25] Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. , 2010, MMWR. Morbidity and mortality weekly report.
[26] J. Högel,et al. Consumption of Imipenem Correlates with β-Lactam Resistance in Pseudomonas aeruginosa , 2002, Antimicrobial Agents and Chemotherapy.
[27] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.